HCA Data Explorer

Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment

Updated January 25, 2023

Immunotherapies have been explored in treating solid tumors, albeit with disparate clinical effects in distinct cancer types. Systematic interrogation of immune cells in the tumor microenvironment (TME) is vital to the prediction of immunotherapy response and the development of innovative immunotherapeutics. To comprehensively characterize the immune microenvironment in advanced biliary tract cancer (BTC), we utilized single-cell RNA sequencing in unselected viable cells from 16 matched samples. We identified nineteen cell subsets from a total of 45,851 cells, in which exhausted CD8+ T cells, macrophages, and dendritic cells (DCs) in BTC were shown to augment and communicate within the TME. Transcriptional profiles coupled with T cell receptor (TCR) sequences revealed that exhausted CD8+ T cells retained clonal expansion and high proliferation in the TME, and some of them highly expressed the endoplasmic reticulum stress (ER) sensor XBP1, indicating its key role in remodeling TME. Functional assays demonstrated that XBP1 and common immune checkpoints (PD1, TIGIT) were significantly upregulated in CD8+ T cells cocultured within the TME of BTC cell lines (GBC-SD, HCCC-9810). When treating the coculture groups with the specific inhibitor of IRE1α-XBP1 (4μ8C), the downregulation of TIGIT was observed in the treatment group. Collectively, comprehensive transcriptome profiling provides deeper insights into the immune atlas in advanced BTC, which might be instrumental in exploring novel immunotherapy strategies. Overall design: Five patients diagnosed with cholangiocarcinoma in the Eastern Hepatobiliary Surgery Hospital were incorporated into the current study, including two intrahepatic cholangiocarcinoma (iCCA), two gallbladder carcinoma (GBC) and one dCCA patients. Of note, none of the patients have undergone any preoperative treatments (chemotherapy, radiation or anti-tumor medicines) prior to tumor resection. Tumor primary locus and metastasis as well as lymph node were consistently harvested for each participant, if available. Meanwhile, peripheral blood samples were collected prior to surgical procedures using anticoagulant tubes.

Hongyang WangEastern Hepatobiliary Surgery Institutehywangk@vip.sina.com
Xiaoqing JiangEastern Hepatobiliary Surgery Hospitaljxq1225@sina.com
Lei ChenEastern Hepatobiliary Surgery Hospitalchenlei@smmu.edu.cn
Hongyang Wang (Experimental Scientist)1
Xiaoqing Jiang (Experimental Scientist)2
Lei Chen (Experimental Scientist)2
Xuebing Shi2
Zhixuan Li2
Renqi Yao3
Qingbao Cheng2
Wei Li2
Rui Wu2
Zhihua Xie2
Yanjing Zhu2
Xinyao Qiu4
Shuai Yang4
Tao Zhou2
Ji Hu2
Yangqianwen Zhang2
Tong Wu2
Yan Zhao4
Yani Zhang4
Jianmin Wu4
Hongyang Wang5
1Eastern Hepatobiliary Surgery Institute
2Eastern Hepatobiliary Surgery Hospital
3Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital
4Fudan University
5National Center for Liver Cancer
Brittney D Wick

To reference this project, please use the following link:

https://explore.data.humancellatlas.dev.clevercanary.com/projects/28371655-60ba-449e-a303-5859b29ead65
None
GEO Series Accessions:INSDC Project Accessions:INSDC Study Accessions:

Atlas

None

Analysis Portals

None

Project Label

biliaryTractCancerImmuneAtlas

Species

Homo sapiens

Sample Type

specimens

Anatomical Entity

5 anatomical entities

Organ Part

2 organ parts

Selected Cell Types

5 cell types

Disease Status (Specimen)

3 disease statuses

Disease Status (Donor)

3 disease statuses

Development Stage

human adult stage

Library Construction Method

2 library construction methods

Nucleic Acid Source

single cell

Paired End

false

Analysis Protocol

analysis_protocol_1, analysis_protocol_2

File Format

5 file formats

Cell Count Estimate

45.9k

Donor Count

5
csv.gz16 file(s)fastq.gz114 file(s)mtx.gz16 file(s)tsv.gz32 file(s)xlsx1 file(s)